Read + Share
Du J, Bai D, Gu C, Zhao J, et al. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism
to evade its anti-hepatocellular carcinoma efficacy. Oncogene 2024 Sep 4. doi: 10.1038/s41388-024-03142.
PMID: 39232218
|
 |
|
Du J, Bai D, Gu C, Zhao J, et al. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism
to evade its anti-hepatocellular carcinoma efficacy. Oncogene 2024 Sep 4. doi: 10.1038/s41388-024-03142.
PMID: 39232218
|
|
|
|